Shareholders Service

Welcome to Vetco's investment center!

Vetco Pharmaceuticals Inc. is a pharmaceutical company specializing in researching and developing innovative novel drug products. Our first invention JPJY-B10- a combination drug- is an anticancer agent which has great potential to treat a variety adenocarcinoma types in human. Although the clinical targets are various human cancers, JPJY-B10 has been fully developed in Taiwan for treatment of canine perianal gland tumor, under the name Antican®. Antican® is also the first anticancer drug for companion animal use in Asia. Vetco, with its professional R&D background, besides innovating novel product to facilitate medical practice, will also continue to enhance the specifications of domestic production plants to achieve PIC/S GMP standard. Our goal, starting from Taiwan, is to expand to become a recognized pharmaceutical company in Asia and ultimately in the global pharmaceutical market.

For further information, please refer to the following section:

Basic Information:
Vetco Pharmaceuticals Inc.
Address:    22F-1, No.97, Sec. 4, Chongxin Rd., Sanchong Dist., New Taipei City, Taiwan (R.O.C.)
Tel:    +886-2-2977-5757

TWSE Market Observation Post System
Sort Name: Vetco

Stock Code: 6520


Shareholders Meetings

Stock Affairs

Financial Report

IR Contacts:
Stock Transfer Agent Capital Securities Corporation
Address: B2, No.97, Sec. 2, Tun Hwq South Rd., Taipei
Tel: +886-2-2703-5000